Similar articles

• Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy.

  Grosso LM, Bracken MB. Grosso LM, et al. Ann Epidemiol. 2005 Jul;15(6):460-6. doi: 10.1016/j.annepidem.2004.12.011. Ann Epidemiol. 2005. PMID: 15967394 Review.
• Caffeine during pregnancy: how much is safe?

  Theroux R. Theroux R. Nurs Womens Health. 2008 Jun;12(3):240-2. doi: 10.1111/j.1751-486X.2008.00329.x. Nurs Womens Health. 2008. PMID: 18557854 No abstract available.
• Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction.

  Grosso LM, Triche EW, Belanger K, Benowitz NL, Holford TR, Bracken MB. Grosso LM, et al. Am J Epidemiol. 2006 Jun 1;163(11):1035-41. doi: 10.1093/aje/kwj125. Epub 2006 Apr 26. Am J Epidemiol. 2006. PMID: 16641310
• Nicotine dose-concentration relationship and pregnancy outcomes in rat: biologic plausibility and implications for future research.

  Hussein J, Farkas S, MacKinnon Y, Ariano RE, Sitar DS, Hasan SU. Hussein J, et al. Toxicol Appl Pharmacol. 2007 Jan 1;218(1):1-10. doi: 10.1016/j.taap.2006.10.019. Epub 2006 Oct 28. Toxicol Appl Pharmacol. 2007. PMID: 17141291
• Pregnancy outcomes, embryonic and fetal development in maternal exposure to Chinese medicines.

  Wang CC, Li L, San Lau CB, Leung PC, Fung KP. Wang CC, et al. Birth Defects Res C Embryo Today. 2013 Dec;99(4):275-91. doi: 10.1002/bdrc.21050. Birth Defects Res C Embryo Today. 2013. PMID: 24339038 Review.